DHSC Claim update – Trial date listed
30/01/2023
RNS
Full Year 2022 Trading Update
26/01/2023
Holdings in Company
06/01/2023
Liquidity Agreement and Total Voting Rights
03/01/2023
Non-Executive Director Change
07/12/2022
Approval of genesig COVID-19 3G PCR test in UK
06/12/2022
01/12/2022
Directorate Change
10/11/2022
01/11/2022
CORRECTION: UK CTDA approval of Winterplex 3G
27/10/2022
UK Approval of genesig® SARS-CoV-2 Winterplex® 3G
26/10/2022
03/10/2022
Half year 2022 results
29/09/2022
Notice of Results and Investor Presentation
15/09/2022
01/09/2022
Launch of first fully lyophilised PROmate® assays
04/08/2022
01/08/2022
Launch of research-use-only adenovirus F41 assay
28/07/2022
Results of AGM
20/07/2022
Director/PDMR Shareholding
15/07/2022
For Investor Relations Support for the Novacyt Group, please click the button below to contact our team.
